These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16540249)

  • 1. Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians.
    Bennett MI; Smith BH; Torrance N; Lee AJ
    Pain; 2006 Jun; 122(3):289-294. PubMed ID: 16540249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
    Bennett MI; Smith BH; Torrance N; Potter J
    J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire.
    Koc R; Erdemoglu AK
    Pain Med; 2010 Jul; 11(7):1107-14. PubMed ID: 20456071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational study.
    Hans G; Masquelier E; De Cock P
    BMC Public Health; 2007 Jul; 7():170. PubMed ID: 17650299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of self report version of the Leeds Assessment of Neuropathic Symptoms and Signs score for identification of neuropathic pain in patients from northern Turkey.
    Türkel Y; Türker H; Demir IA; Bayrak AO; Onar MK
    Adv Clin Exp Med; 2014; 23(4):599-603. PubMed ID: 25166445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.
    Batistaki C; Lyrakos G; Drachtidi K; Stamatiou G; Kitsou MC; Kostopanagiotou G
    Pain Pract; 2016 Jun; 16(5):552-64. PubMed ID: 25880345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
    Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
    J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.
    Walker SM; Peters J; Verriotis M; Farag F; Jay MA; Howard RF
    J Pain; 2024 Feb; 25(2):451-465. PubMed ID: 37741521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Leeds Assessment of Neuropathic Symptoms and Signs Scale (LANSS) is not an adequate outcome measure of pressure ulcer-related neuropathic pain.
    Rutherford C; Nixon JE; Brown JM; Briggs M; Horton M
    Eur J Pain; 2016 Nov; 20(10):1710-1720. PubMed ID: 27172978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.
    Bennett M
    Pain; 2001 May; 92(1-2):147-57. PubMed ID: 11323136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain.
    Walsh J; Rabey MI; Hall TM
    J Manipulative Physiol Ther; 2012; 35(3):196-202. PubMed ID: 22397741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic workup of patients with neuropathic pain.
    Horowitz SH
    Med Clin North Am; 2007 Jan; 91(1):21-30. PubMed ID: 17164102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuropathic pain component among patients with chronic low back-radicular pain.
    Sivas F; Uzun Ö; Başkan B; Bodur H
    J Back Musculoskelet Rehabil; 2018; 31(5):939-946. PubMed ID: 29945338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community.
    Smith BH; Torrance N; Bennett MI; Lee AJ
    Clin J Pain; 2007 Feb; 23(2):143-9. PubMed ID: 17237663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of neuropathic pain among patients with chronic low-back pain in the Arabian Gulf Region assessed using the leeds assessment of neuropathic symptoms and signs pain scale.
    El Sissi W; Arnaout A; Chaarani MW; Fouad M; El Assuity W; Zalzala M; Dershaby YE; Youseif E
    J Int Med Res; 2010; 38(6):2135-45. PubMed ID: 21227019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that affect the number of tender points in fibromyalgia and chronic widespread pain patients who did not meet the ACR 1990 criteria for fibromyalgia: are tender points a reflection of neuropathic pain?
    Pamuk ON; Yeşil Y; Cakir N
    Semin Arthritis Rheum; 2006 Oct; 36(2):130-4. PubMed ID: 16884973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-cultural Adaptation and Linguistic Validation of the Korean Version of the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale.
    Park C; Lee YW; Yoon DM; Kim DW; Nam DJ; Kim DH
    J Korean Med Sci; 2015 Sep; 30(9):1334-9. PubMed ID: 26339176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the LANSS scale be used to classify pain in chronic cancer pain trials?
    Hardy J; Quinn S; Fazekas B; Agar M; Currow D
    Support Care Cancer; 2013 Dec; 21(12):3387-91. PubMed ID: 23934225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Behcet's disease associate with neuropathic pain syndrome and impaired well-being?
    Evcik D; Dogan SK; Ay S; Cuzdan N; Guven M; Gurler A; Boyvat A
    Clin Rheumatol; 2013 Jan; 32(1):33-6. PubMed ID: 23001467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation and linguistic validation of the self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) scale for use in a Libyan population.
    Elzahaf RA; Tashani OA; Unsworth BA; Johnson MI
    Pain Pract; 2013 Mar; 13(3):198-205. PubMed ID: 22726274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.